Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water

Abstract

Maximum contaminant levels are used to control potential health hazards posed by chemicals in drinking water, but no primary national or international limits for aluminum (Al) have been adopted. Given the differences in toxicological profiles, the present evaluation derives total allowable concentrations for certain water-soluble inorganic Al compounds (including chloride, hydroxide, oxide, phosphate and sulfate) and for the hydrated Al silicates (including attapulgite, bentonite/montmorillonite, illite, kaolinite) in drinking water. The chemistry, toxicology and clinical experience with Al materials are extensive and depend upon the particular physical and chemical form. In general, the water solubility of the monomeric Al materials depends on pH and their water solubility and gastrointestinal bioavailability are much greater than that of the hydrated Al silicates. Other than Al-containing antacids and buffered aspirin, food is the primary source of Al exposure for most healthy people. Systemic uptake of Al after ingestion of the monomeric salts is somewhat greater from drinking water (0.28%) than from food (0.1%). Once absorbed, Al accumulates in bone, brain, liver and kidney, with bone as the major site for Al deposition in humans. Oral Al hydroxide is used routinely to bind phosphate salts in the gut to control hyperphosphatemia in people with compromised renal function. Signs of chronic Al toxicity in the musculoskeletal system include a vitamin D-resistant osteomalacia (deranged membranous bone formation characterized by accumulation of the osteoid matrix and reduced mineralization, reduced numbers of osteoblasts and osteoclasts, decreased lamellar and osteoid bands with elevated Al concentrations) presenting as bone pain and proximal myopathy. Aluminum-induced bone disease can progress to stress fractures of the ribs, femur, vertebrae, humerus and metatarsals. Serum Al ≥100 µg/L has a 75-88% positive predictive value for Al bone disease. Chronic Al toxicity is also manifest in the hematopoietic system as an erythropoietin-resistant microcytic hypochromic anemia. Signs of Al toxicity in the central nervous system (speech difficulty to total mutism to facial grimacing to multifacial seizures and dyspraxia) are related to Al accumulation in the brain and these symptoms can progress to frank encephalopathy. There are four groups of people at elevated risk of systemic Al intoxication after repeated ingestion of monomeric Al salts: the preterm infant, the infant with congenital uremia and children and adults with kidney disease. There is a dose-dependent increase in serum and urinary Al in people with compromised renal function, and restoration of renal function permits normal handling of systemically absorbed Al and resolution of Al bone disease. Clinical experience with 960 mg/day of Al(OH)(3) (~5 mg Al/kg-day) given by mouth over 3 months to men and women with compromised renal function found subclinical reductions in hemoglobin, hematocrit and serum ferritin. Following adult males and females with reduced ki...

Enhanced synergistic denitrification and chemical precipitation in a modified BAF process by using Fe2+

“…Al salts are relatively costly, and residual Al in effluent would arouse concerns on the risk of neurologic diseases potentially associated with long-term exposure to Al in environments (Willhite et al, 2012). Ferric chloride and ferrous sulfate are the most used Fe salts.…”

Trace Elements in Patients with Chronic Kidney Disease

“…However, aluminum accumulates in patients with CKD due to reduced renal clearance. Aluminum exposure may result from contamination of domestic water due to treatment with aluminum salts used to precipitate particulate matter to improve water clarity appearance, 63 and from leaching from aluminumcoated cooking utensils. 64 In addition some patients with CKD may be prescribed aluminum-containing medicines, not only as phosphate binders but also antacids.…”

The use of aluminum and its compounds in the biomedical purposes

“…Особливо це стосується вмісту спо-лук алюмінію у питній воді та зростання спо-живання харчових продуктів, які забруднені цим металом [11,13,36]. Нині існують дані, інколи навіть протилежні, щодо токсичності наночастинок сполук алюмінію для клітин різних біооб'єктів [14,18,27,32,33,37,38].…”